Jones Financial Companies
KYMR icon

Jones Financial Companies’s Kymera Therapeutics KYMR Stock Holding History

Jones Financial Companies’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.5K Buy
1,209
+988
+447% +$78.2K ﹤0.01% 2696
2025
Q4 		$17.2K Buy
221
+19
+9% +$1.28K ﹤0.01% 3001
2025
Q3 		$11.4K Buy
202
+111
+122% +$5.01K ﹤0.01% 3032
2025
Q2 		$4.01K Buy
91
+50
+122% +$1.72K ﹤0.01% 3211
2025
Q1 		$1.21K Buy
+41
New +$1.5K ﹤0.01% 3357

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return